WASHINGTON DC (October 11, 2019) — Senate Finance Committee Chairman Charles "Chuck" Grassley today released the following statement regarding the Congressional Budget Office’s (CBO) analysis of Speaker Nancy Pelosi’s legislation to lower prescription drug prices.

“I’m glad the House of Representative is working on prescription-drug legislation. Lowering costs for patients and tax-payers while protecting American medical-innovation should be the goal. Any bill must also be bipartisan so it can pass both chambers of Congress and be signed into law by President Trump. As chairman of the Senate Finance Committee, the legislation I authored with Ranking Member [Ron] Wyden strikes that balance and would achieve real progress for Americans. To date, it’s the only significant, bipartisan legislation to lower prescription-drug prices that’s passed a congressional committee. I urge my colleagues in the House and the Senate to get to work to lower costs while ensuring life-saving treatments can continue to be developed right here in America,” Sen Grassley said.

The Grassley/Wyden Prescription Drug Pricing Reduction Act (PDPRA), S2543, passed out of the Senate Finance Committee this July with a broad, bipartisan 19-9 vote. It would save taxpayers more than $100 billion and save beneficiaries more than $30 billion in out-of-pocket costs.

Support the River Cities' Reader

Get 12 Reader issues mailed monthly for $48/year.

Old School Subscription for Your Support

Get the printed Reader edition mailed to you (or anyone you want) first-class for 12 months for $48.
$24 goes to postage and handling, $24 goes to keeping the doors open!

Click this link to Old School Subscribe now.



Help Keep the Reader Alive and Free Since '93!

 

"We're the River Cities' Reader, and we've kept the Quad Cities' only independently owned newspaper alive and free since 1993.

So please help the Reader keep going with your one-time, monthly, or annual support. With your financial support the Reader can continue providing uncensored, non-scripted, and independent journalism alongside the Quad Cities' area's most comprehensive cultural coverage." - Todd McGreevy, Publisher